Cancer recurrence is not a failure of surgical skill -  it is a failure of visibility

Despite decades of innovation, cancer surgery still relies heavily on:

• preoperative imaging that is no longer accurate once surgery begins

• subjective visual assessment of tissue

• incomplete or inconsistent fluorescence signals

In brain tumors, this results in:

• residual infiltrative disease at the margins

• high local recurrence rates

• a forced trade-off between aggressive resection and neurological safety

Bold Statement

Cancer recurrence is not a failure of surgical skill — it is a failure of visibility.

Key Capabilities

• Detects tumor tissue beyond conventional 'incorrect' margins

• Quantifies tissue biology instead of relying on subjective visual cues

• Provides immediate, actionable feedback to the surgeon

• Integrates into existing surgical workflows without disruption

•  

This is not another imaging modality. It is a new way of seeing tissue.

Illuminating the Unknown:

Transforming Cancer Surgery with Optical Fingerprinting!

Cancer surgery is still fundamentally constrained by what surgeons can see. MRI, neuronavigation, and even fluorescence-guided surgery provide valuable information — but all leave critical blind spots at the tumor–normal tissue interface.

This limitation is most devastating in the brain, where:

• microscopic tumor infiltration drives recurrence, and

• millimeters can mean the difference between cure and permanent neurological injury.

•  

Oncolight changes this paradigm.

We introduce a new layer of biological intelligence into the operating room: optical fingerprinting — the ability to detect and classify tissue based on its intrinsic optical signature, in real time, during surgery.

Same core technology designed to scale into

• Spine and skull base tumors

• Head & neck oncology

• Solid tumor margin assessment

• Biopsy guidance and tissue characterization

Brain

• Gliomas and other infiltrative tumors

• Marign detection where recurrence originates

• Real-time guidance during resection

Future Expansion

Strategic Focus 

The brain is the most unforgiving surgical environment

• Functional tissue cannot be sacrificed

• Tumor infiltratin is often invisible

• Outcomes are tightly linked to extent of resection

•  

If a technology can succeed here, it can succeed anywhere

• Quantitative, NOT qualitative

• Real-time, NOT scanning

• Exogenous and intrinsic signals

• Designed for surgery, NOT the lab

•  

WHAT MAKES IT DIFFERENT

• Advanced optical acquisition captures rich spectral information from tissues

• AI-driven algorithms analyze and classify tissue signatures

• Surgeons receive immediate, intuitive feedback during resection

•  

HOW IT WORKS

Every tissue has a unique optical signature shaped by:

• molecular composition

• metabolic state

• vascularity and oxygenation

• microstructural organization

ONCOLIGHT captures and interprets these signatures in real time, transforming light into a quantitative biomarker.